The Finnish Diabetes Prevention Study

被引:0
|
作者
Uusitupa, M
Louheranta, A
Lindström, J
Valle, T
Sundvall, J
Eriksson, J
Tuomilehto, J
机构
[1] Univ Kuopio, Dept Clin Nutr, FIN-70211 Kuopio, Finland
[2] Kuopio Univ Hosp, FIN-70211 Kuopio, Finland
[3] Natl Publ Hlth Inst, Helsinki, Finland
关键词
type; 2; diabetes; impaired glucose tolerance; prevention; diet; exercise; lifestyle;
D O I
暂无
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The aim of the Finnish Diabetes Prevention Study is to assess the efficacy of an intensive diet-exercise programme in preventing or delaying type 2 diabetes in individuals with impaired glucose tolerance (IGT) and to evaluate the effect of the programme on the risk factors of atherosclerotic vascular diseases and the incidence of cardiovascular events. In this ongoing study, a total of 523 overweight subjects with IGT based on two oral glucose tolerance tests were randomized to either an intervention group or a control group. The main measure in the intervention group is individual dietary advice aimed at reducing weight and intake of saturated fat and increasing intake of dietary fibre. The intervention subjects are individually guided to increase their level of physical activity. The control group receives general information about the benefits of weight reduction, physical activity and healthy diet in the prevention of diabetes. A pilot study began in 1993, and recruitment ended in 1998. By the end of April 1999 there were 65 new cases of diabetes, 34 drop-outs and one death. The weight reduction was greater (-4.6 kg) at 1 year in the intervention group (n = 152) than in the control group (n = 143, -0.9 kg, P < 0.0001), and this difference was sustained in the second year of follow-up. At 1 year 43.4 % and at 2 years 41.8 % of the intervention subjects had achieved a weight reduction of at least 5 kg, while the corresponding figures for the control subjects were 14.0 and 12.0 % (P < 0.001 between the groups). At 1 year the intervention group showed significantly greater reductions in 2 h glucose, fasting and 2 h insulin, systolic and diastolic blood pressure, and serum triglycerides. Most of the beneficial changes in cardiovascular risk factors were sustained for 2 years. These interim results of the ongoing Finnish Diabetes Prevention Study demonstrate the efficacy and feasibility of the lifestyle intervention programme.
引用
收藏
页码:S137 / S142
页数:6
相关论文
共 50 条
  • [41] The genetic variation in the gene (TNMD) is associated with impaired glucose metabolism and conversion to type 2 diabetes in men of the Finnish Diabetes Prevention Study
    Tolppanen, A-M.
    Pulkkinen, L.
    Kolehmainen, M.
    Salopuro, T.
    Schwab, U.
    Tuomilehto, J.
    Uusitupa, M.
    DIABETOLOGIA, 2006, 49 : 36 - 36
  • [42] Longitudinal serum branched-chain amino acids, lifestyle intervention and the risk of type 2 diabetes in the Finnish Diabetes Prevention study
    Kivela, J.
    Meinila, J.
    Uusitupa, M.
    Tuomilehto, J.
    Lindstrom, J.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S4 - S5
  • [43] Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance -: The Finnish diabetes prevention study
    Niskanen, L
    Laaksonen, DE
    Lindström, J
    Eriksson, JG
    Keinänen-Kiukaanniemi, S
    Ilanne-Parikka, P
    Aunola, S
    Hämäläinen, H
    Tuomilehto, J
    Uusitupa, M
    DIABETES CARE, 2006, 29 (03) : 709 - 711
  • [44] Costs of a self-selected, health-promoting diet among the participants of the Finnish Diabetes Prevention Study
    Ottelin, Anne-Mari
    Lindstrom, Jaana
    Peltonen, Markku
    Martikainen, Janne
    Uusitupa, Matti
    Gylling, Helena
    Poutanen, Kaisa
    Louheranta, Anne
    Mannelin, Marjo
    Paturi, Merja
    Salminen, Virpi
    Tuomilehto, Jaakko
    DIABETES CARE, 2007, 30 (05) : 1275 - 1277
  • [45] Eating behavior dimensions and 9-year weight loss maintenance: a sub-study of the Finnish Diabetes prevention study
    Jutta Salmela
    Hanna Konttinen
    Raimo Lappalainen
    Joona Muotka
    Anne Antikainen
    Jaana Lindström
    Jaakko Tuomilehto
    Matti Uusitupa
    Leila Karhunen
    International Journal of Obesity, 2023, 47 : 564 - 573
  • [46] The genetic variation in the tenomodulin gene is associated with serum levels of systemic immune mediators -: the Finnish Diabetes Prevention Study
    Tolppanen, A.-M.
    Pulkkinen, L.
    Herder, C.
    Koenig, W.
    Lindstrom, J.
    Tuomilehto, J.
    Uusitupa, M.
    DIABETOLOGIA, 2007, 50 : S166 - S166
  • [47] Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance.: The Finnish Diabetes Prevention Study
    Hamalainen, H
    Rönnemaa, T
    Virtanen, A
    Lindström, J
    Eriksson, JG
    Valle, TT
    Ilanne-Parikka, P
    Keinanen-Kiukaanniemi, S
    Rastas, M
    Aunola, S
    Uusitupa, M
    Tuomilehto, J
    DIABETOLOGIA, 2005, 48 (11) : 2248 - 2253
  • [48] Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study
    H. Hämäläinen
    T. Rönnemaa
    A. Virtanen
    J. Lindström
    J. G. Eriksson
    T. T. Valle
    P. Ilanne-Parikka
    S. Keinänen-Kiukaanniemi
    M. Rastas
    S. Aunola
    M. Uusitupa
    J. Tuomilehto
    Diabetologia, 2005, 48 : 2248 - 2253
  • [49] Eating behavior dimensions and 9-year weight loss maintenance: a sub-study of the Finnish Diabetes prevention study
    Salmela, Jutta
    Konttinen, Hanna
    Lappalainen, Raimo
    Muotka, Joona
    Antikainen, Anne
    Lindstrom, Jaana
    Tuomilehto, Jaakko
    Uusitupa, Matti
    Karhunen, Leila
    INTERNATIONAL JOURNAL OF OBESITY, 2023, 47 (07) : 564 - 573
  • [50] Genetic screening for type 1 diabetes based on HLA-DQ typing in the general population.: The Finnish Diabetes Prediction and Prevention Study
    Ilonen, J
    Reijonen, H
    Sjöroos, M
    Nejentsev, S
    Knip, M
    Simell, O
    TISSUE ANTIGENS, 2002, 59 : 17 - 17